Please assess the completion status of the following clinical trial:

Trial Title: Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Key Inclusion Criteria:~* Men and non-pregnant, non-breastfeeding women~* 18 years or older~* Scheduled for knee replacement surgery~Key Exclusion Criteria:~* hereditary or acquired bleeding disorders~* clotting disorders~* bleeding or high risk for bleeding~* drugs that affect bleeding or coagulation~* need for ongoing parenteral or oral anticoagulation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A1 (Type: ACTIVE_COMPARATOR): + placebo
- A2 (Type: EXPERIMENTAL): + placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).